Editorial Governance
The iMedix standard for public submissions and user-generated health content, and the record of its permanent removal in August 2026.
iMedix does not publish user-generated health content or accept public submissions for publication. In August 2026, user comments, community questions and other public submissions were permanently discontinued, and previously published material associated with those features was removed from the iMedix publishing system.
Record of the change
We publish the specifics of this change because readers who previously encountered comments, questions or community features on iMedix should be able to understand why those features are no longer part of the publication.
The principle
Health information published by iMedix is expected to have identifiable authorship or editorial responsibility, appropriate medical review, and traceable supporting sources under our current editorial standards. Anonymous or unverifiable public submissions cannot meet those requirements.
Personal experiences can be meaningful to the person describing them, but they are not equivalent to clinically reviewed evidence. iMedix therefore does not present patient comments, testimonials, community answers or other public submissions alongside reviewed medical information as evidence or guidance.
Scope
This policy applies to public user-generated health content throughout iMedix, including:
- comments on medicine, condition, treatment and other health-information pages,
- community questions and answers,
- patient experiences and testimonials submitted for public display,
- public discussions concerning medicines, dosages, interactions, treatments or medical conditions,
- public contributor accounts created for the purpose of submitting such material.
This policy does not prevent readers from privately contacting iMedix to report an error, ask an administrative question, exercise a privacy right, or provide feedback that is not submitted for public publication.
Professional profiles for iMedix authors, medical reviewers and other verified contributors are not user-generated community accounts. They exist to identify the people professionally responsible for content and review.
Why iMedix does not publish public health submissions
Clinical claims require provenance
A substantive medical claim should be traceable to evidence that can be examined and verified. Anonymous or unverifiable public submissions do not provide that evidentiary chain.
Personal experience can be mistaken for instruction
An account of a dose, combination, treatment or duration that worked for one person may be interpreted by another reader as a recommendation. Appropriate treatment can depend on diagnosis, age, concurrent medicines, organ function and other individual factors that cannot be established through a public comment.
Medicine procurement discussions are outside our publishing model
iMedix does not provide a public channel for instructions on obtaining prescription-only medicines without a prescription or outside regulated supply.
Public comments are not a safety-reporting system
A suspected adverse reaction requires an appropriate healthcare or regulatory reporting channel. A comment or community post does not provide that function.
What stands in its place
Instead of public submissions, iMedix relies on an editorial model built around identifiable responsibility, professional review and traceable evidence:
Attributed responsibility
Medical content identifies the author, medical writer or editorial responsibility applicable to the page under the current iMedix publishing standard.
Medical review
Medical content subject to clinical review is evaluated by a licensed healthcare professional with relevant expertise under the Editorial Policy.
Review and update dates
Applicable publication, content update and medical review dates provide readers with information about when medical material was evaluated or revised.
Traceable sources
Clinical claims are supported by appropriate regulatory information, clinical guidance and scientific literature according to the question being answered.
Market-specific information
Where regulatory status is relevant, it is identified for the market the edition serves rather than assumed from another jurisdiction.
A correction route
Readers can report factual or medical errors, which are evaluated and corrected under the process described in the Editorial Policy.
Reporting a suspected side effect
If you believe a medicine has caused a serious or unexpected reaction, seek appropriate medical advice. Suspected adverse reactions can also be reported through the relevant national medicines regulator.
iMedix is a publisher of health information. It is not a marketing authorisation holder and does not operate a pharmacovigilance system. Reports or messages sent to iMedix are not submitted to medicines regulators on a reader’s behalf.
What we still want to hear
Ending public submissions does not prevent readers from reporting problems with our content. If a page contains a factual error, outdated information, an incorrect dosage figure, or a claim that does not match its cited source, please tell us. Reported issues are evaluated under the corrections process described in our Editorial Policy.
How iMedix is governed
This policy should be read together with the other documents describing how iMedix produces, reviews and funds its content.
Document control
Effective from: 28 August 2026
Updated: 1 September 2026
Applies to: imedix.com — English, German and French editions
Owner: iMedix Editorial Team
Review basis: On material change to the iMedix publishing model, editorial standards, or applicable requirements
Last reviewed: 1 September 2026
